19th - 20th September 2018, Minneapolis, USA

3rd Risk Based Quality Management for Medical Devices Conference

The 3rd Risk Based Quality Management for Medical Devices conference presents a unique and holistic approach to effectively managing risk. You will hear recent case studies on incorporating a robust yet agile risk based framework to proactively address global compliance standards and achieve highest product safety.

11th - 12th September 2018, Philadelphia, USA

Digital Innovation in Clinical Trials Conference

The Digital Innovation in Clinical Trials Conference will bring together the foremost leaders in Clinical Innovation, Clinical Development, Clinical Operations, Clinical R&D, and Digital Clinical Trials to explore ways to incorporate innovative technologies and digital strategies into clinical trial frameworks.

Hear key practical case studies from companies such as GSK, AstraZeneca, Pfizer, AbbVie, GlaxoSmithKline, Daiichi Sankyo, Inc., Amgen, and many more!



20th - 21st September 2018, Philadelphia, USA

8th Annual Pharmacovigilance, Drug Safety & Risk Management Conference

The 8th Annual Pharmacoviligance, Drug Safety & Risk Management Conference will address emerging trends in risk management, reporting automation and other surveillance strategies. Participants will discuss the latest strategies and tactics in building a comprehensive enterprise wide PV framework. Hear key practical case studies from companies such as AstraZeneca, Incyte, AbbVie, Bristol-Myers Squibb, GlaxoSmithKline, Pfizer, Celgene, and many more!

12th - 13th September 2018, London, UK

Real World Evidence & Advanced Data Strategy

This conference will facilitate dialogue and exchanges among stakeholders about the real application, impact and opportunity in incorporating RWE in all stage of the drug and product strategy, exploring unmet needs, precision medicine and new opportunities to meet patient’s needs.

Integrating the complexity of information about patients in the medical product development is one of the challenges that the pharmaceutical industry needs to take.The increase in the generation and use of Real World Evidence and Big Data in health product provides a great opportunity for both pharma and patients to determine more effective treatments and evaluation of therapeutics. 

6th - 8th November 2018, Barcelona, Spain

World Orphan Drug Congress 2018

The 9th annual World Orphan Drug Congress is the marketplace for orphan drug professionals looking at the complete value chain of orphan drug development, from clinical development and R&D to corporate development and market access. Now recognised as the largest and most established European orphan drug event, we are once again proud to deliver another outstanding speaker line-up and a content-filled agenda that represents the whole orphan drug landscape.



10th - 11th September 2018, Amsterdam, The Netherlands

World Drug Safety Congress 2018

The World Drug Safety Congress Europe will bring together key thought leaders and experts to explore these worldwide challenges. Explore the use of big data and AI in pharmacovigilance, examine benefit-risk management strategies and patient-centric approaches; discuss how you can tackle the challenges of social media and drug safety legislation globally. Make sure you are at the heart of the new drug safety era and participate in these critical discussions.



More Articles ...